Percutaneous Coronary Intervention: Procedures, Medical Uses and Adverse Effects

Huili Gan and Yujie Zhou (Editors)
Anzhen Hospital, Affiliated to Capital University of Medical Sciences, Beijing, China

Series: Cardiology Research and Clinical Developments
BISAC: MED010000

Clear

Volume 10

Issue 1

Volume 2

Volume 3

Special issue: Resilience in breaking the cycle of children’s environmental health disparities
Edited by I Leslie Rubin, Robert J Geller, Abby Mutic, Benjamin A Gitterman, Nathan Mutic, Wayne Garfinkel, Claire D Coles, Kurt Martinuzzi, and Joav Merrick

eBook

Digitally watermarked, DRM-free.
Immediate eBook download after purchase.

Product price
Additional options total:
Order total:

Quantity:

Details

Percutaneous coronary intervention (PCI) has entered its third decade, as it had gone through a PTCA era, BMS era, and entered into the DES era. This book summarizes information gathered from recent literature in the field of PCI, focusing on PCI procedures, adjunctive pharmacotherapy and adverse effects. The editor has put together a comprehensive, in-depth guide to PCI, which has seen great advances in the understanding and management of coronary artery disease in recent years. The book examines all aspects of PCI in detail, in isolation and in combination with procedures, or medical uses and its adverse effects, to fulfill the aim of helping healthcare professionals and medical students to better understand and manage PCI problems in the DES era. (Imprint: Nova Biomedical )

Preface pp. i-ix

Editor’s Affiliation

Chapter I. Coronary Artery Lesion Assessment Techniques
(Haris Zafarullah, Kedar Sankholkar, Jay V. Doshi, Wilbert S. Aronow and William Gotsis, Cardiology Division, Westchester Medical Center/New York Medical College, Valhalla, NY, USA)pp. 1-20

Chapter II. Functional Coronary Magnetic Resonance Imaging
(Sebastian Kelle, Department of Internal Medicine/Cardiology, Deutsches Herzzentrum Berlin, Germany)pp. 21-32

Chapter III. Inner Catheter Use for Coronary Angioplasty
(Takashi Ashikaga, Department of Cardiovascular Medicine,Tokyo Medical and Dental University, Tokyo, Japan) pp. 33-44

Chapter IV. Nucleic Acid Drugs to Prevent Restenosis after Coronary Intervention – From Bench to Bedside
(Jun-ichi Suzuki, Ryuichi Morishita, Yasunobu Hirata and Mitsuaki Isobe, Department of Advanced Clinical Science and Therapeutics, University of Tokyo, Tokyo, Japan, and others)pp. 45-52

Chapter V. Pharmacological Agents During Percutaneous Coronary Intervention
(David C. Yang, Rajesh V. Swaminathan, Luke K. Kim and Dmitriy N. Feldman, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA) pp. 53-108

Chapter VI. Off-pump Coronary Artery Bypass Surgery is a Safe Revascularization Procedure for Left Main Coronary Artery Lesion — Our Experience
(Hui-li Gan, Jian-qun Zhang, Fang-jong Huang, Cheng-xiong Gu, Qing-yu Kong, Xiong-rong Cao, Ping Bo, Pi-shan Wang, Tong Liu and Chun-shang Lu, Cardiac Surgery Department, Beijing Anzhen Hospital, and
Capital Medical University (BAZH—CMU), Beijing Institute of Heart, Lung and Blood Vessel Disease, Beijing, China, and others)pp. 109-128

Chapter VII. Ostial Right Coronary Lesions: A Comparison between Percutaneous Coronary Intervention and Coronary Artery Bypass Grafts Adjusted by Propensity Score
(Hui-li Gan, Tong Liu and Chun-shang Lu, Beijing Anzhen Hospital, Beijing, China, and others)pp. 129-148

Index pp. 149-157

You have not viewed any product yet.